Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2002-11-13 | Martin Zeiger (65) has been a director since October 2001. ... Member of Audit and Corporate Governance Committees. |
| 2003-09-23 | Martin Zeiger (66) has been a director since October 2001 ... (2) Member of the Audit Committee; (4) Member of the Corporate Governance Committee; |
| 2004-09-27 | Martin Zeiger (67) has been a director since October 2001. Mr. Zeiger is an independent consultant to the pharmaceutical industry. |
| 2005-09-27 | Martin Zeiger (68) has been a director since October 2001. Mr. Zeiger is an independent consultant to the pharmaceutical industry. Mr. Zeiger was Senior Vice President of Strategic Business Development for Barr Laboratories, a drug manufacturer, from 1999 through August 2003. From 1987 through 1999, Mr. Zeiger was Executive Vice President and General Counsel for Rugby Laboratories. In 1993 Marion Merrill Dow acquired Rugby Laboratories. Mr. Zeiger was a Vice President of Marion Merrill Dow, Inc. and its successor Hoechst Marion Roussell, Inc. Mr. Zeiger is a member of the Heritage Board of Directors of the American Heart Association in New York and a founding director of the Larry King Cardiac Foundation. |
| 2009-08-21 | Martin Zeiger has been a director since October 2001. ... The Compensation Committee consisted of Martin Zeiger, who serves as the committee chair, Dr. Derek Enlander and Photios T. Paulson. ... The Corporate Governance Committee consisted of Dr. John C.K. Hui, who serves as committee chair, Simon Srybnik and Martin Zeiger. ... The Audit Committee during fiscal 2009 consisted of Joseph A. Giacalone, Martin Zeiger and Photios T. Paulson who became committee chairman following Mr. Giacalone's resignation. ... Director Compensation table shows Martin Zeiger total compensation as $31,000. |
Data sourced from SEC filings. Last updated: 2025-12-06